Ex Vivo Activity of Immunotherapeutic Approaches Targeting CD38 Against Daratumumab-Resistant Multiple Myeloma Patient Samples

被引：0
|
作者：
Karvouni, Maria [1 ]
Zhou, Heyue [2 ]
Kathleen, Arnika [1 ]
Ma, Qiangzhong [2 ]
Baloch, Alamdar H. [1 ]
Zhu, Tong [2 ]
Zhang, Hong [2 ]
Gilljam, Mari [3 ]
Lundqvist, Andreas [4 ]
Kaufmann, Gunnar F. [2 ]
Alici, Evren [1 ]
机构：
[1] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden
[2] Sorrento Therapeut Inc, San Diego, CA USA
[3] Karolinska Inst, Stockholm, Sweden
[4] Karolinska Inst, Dept Ocol Pathol, Stockholm, Sweden
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127893
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1848
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13): : 1207 - 1219
  • [2] CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
    Morandi, Fabio
    Horenstein, Alberto L.
    Costa, Federica
    Giuliani, Nicola
    Pistoia, Vito
    Malavasi, Fabio
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] CD38 as an immunotherapeutic target in multiple myeloma
    Bonello, Francesca
    D'Agostino, Mattia
    Moscvin, Maria
    Cerrato, Chiara
    Boccadoro, Mario
    Gay, Francesca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (12) : 1209 - 1221
  • [4] CD38 targeting in multiple myeloma
    Abel, Andrea
    Cano, Laia Querol
    van Spriel, Annemiek
    Hammink, Roel
    ter Beest, Martin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S248 - S248
  • [5] Multiomic Analysis of CD38 Expression Levels in 209 Untreated and Daratumumab-Resistant Patients
    Steinhardt, Max Johannes
    Eiring, Patrick
    Munawar, Umair
    Haertle, Larissa
    Han, Seungbin
    Vogt, Cornelia
    Nerreter, Silvia
    Teufel, Eva
    Mersi, Julia
    Bittrich, Max
    Danhof, Sophia
    Truger, Marietta
    Haaf, Thomas
    Barrio, Santiago
    Zhou, Xiang
    Martinez-Lopez, Joaquin
    Haferlach, Claudia
    Hudecek, Michael
    Einsele, Hermann
    Rasche, Leo
    Sauer, Markus
    Kortuem, K. Martin
    BLOOD, 2022, 140 : 4230 - 4231
  • [6] In Vitro and In Vivo Efficacy of CD38 Directed Therapy with Daratumumab In the Treatment of Multiple Myeloma
    Groen, Richard W.
    van der Veer, Michael
    Hofhuis, Frans M.
    van Kessel, Berris
    de Weers, Michel
    Parren, Paul W. H. I.
    Lokhorst, Henk M.
    Mutis, Tuna
    Martens, Anton
    BLOOD, 2010, 116 (21) : 1261 - 1262
  • [7] CD38 Expression Loss in Multiple Myeloma Treated with Daratumumab
    Hotchandani, Nihar
    Fung, Henry
    Dulaimi, Essel
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146
  • [8] Immunotherapies targeting CD38 in Multiple Myeloma
    Atanackovic, Djordje
    Steinbach, Mary
    Radhakrishnan, Sabarinath Venniyil
    Luetkens, Tim
    ONCOIMMUNOLOGY, 2016, 5 (11):
  • [9] Molecular dynamics of targeting CD38 in multiple myeloma
    Malavasi, Fabio
    Faini, Angelo C.
    Morandi, Fabio
    Castella, Barbara
    Incarnato, Danny
    Oliviero, Salvatore
    Horenstein, Alberto L.
    Massaia, Massimo
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 581 - 591
  • [10] Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma
    Kinder, Michelle
    Bahlis, Nizar J.
    Malavasi, Fabio
    de Goeij, Bart
    Babich, Alexander
    Sendecki, Jocelyn
    Rusbuldt, Joshua
    Bellew, Kevin
    Kane, Colleen
    van de Donk, Niels W. C. J.
    HAEMATOLOGICA, 2021, 106 (07) : 2004 - 2008
12345